If you’ve been diagnosed with non-small cell lung cancer (NSCLC), one of the first conversations to have with your clinician should be about testing your tumor tissue for cancer biomarkers. Biomarkers can be gene changes or high levels of proteins that are known to cause cancer. They can give your clinician important information about your cancer, including how it might respond to treatment.“According to National Comprehensive Cancer Network guidelines, everyone with a stage 2 or higher lung cancer should undergo molecular testing,” said David Tom Cooke, M.D., chief of general thoracic surgery...